Pharma News News
Pharma News
Health Ministry Tightens Drug Approval Rules: India Introduces Strict Penalties for Fake or Fabricated Data in Pharma Applications
India has strengthened its pharmaceutical regulatory framework by amending the Drugs Rules, 1945, empowering licensing authorities to temporarily debar companies that submit fake or fabricated data. The move aims to improve drug safety, reinforce scientific integrity, and enhance public trust